Tissue Regeneration Therapeutics agrees to grant the Scottish National Blood and Transfusion Services (SNBTS) an exclusive license, subject to SNBTS securing the requisite funding, to use Human Umbilical Cord Perivascular Cells as an adjunct to the transplantation of pancreatic islets in the United Kingdom.